The company had reported net profit of Rs 262.11 crore in the January-March quarter of financial year 2012-13.
Cadila's net sales in the quarter under review were up by 22.40 per cent to Rs 1,916.33 crore as against Rs 1,565.53 crore in the year-ago period, the company said in a BSE filing.
During the quarter, the company recorded tax expense of Rs 34.76 crore as against a tax credit of Rs 59.02 crore in the corresponding period a year ago.
Cadila Healthcare scrips were trading at Rs 911 apiece in the afternoon trade, down 3.11 per cent from its previous close on the BSE.